14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
Maryland State Governor Larry Hogan issued a revised order yesterday (Order no. 20-03-30-01) whereby...
Read More >
Based on a recent Delaware Chancery Court decision, parties outside of a transaction—not just the b...
Read More >
On March 31, 2020, the six Bay Area counties that previously issued the nation’s first Covid-19 she...
Read More >
Belief in a strong case is not a good enough reason to refuse settlement overtures. So held the cour...
Read More >
One of the amendments we’ve been watching over the past months is one that impacts rights of employ...
Read More >
In Arizona, non-solicitation agreements may be enforceable if they are “reasonable.” This means em...
Read More >